CANTHARIS (HOMEOLAB USA INC)
Welcome to the PulseAid listing for the CANTHARIS drug offered from HOMEOLAB USA INC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | HOMEOLAB USA INC |
| NON-PROPRIETARY NAME: | CANTHARIS |
| SUBSTANCE NAME: | LYTTA VESICATORIA |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | PELLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2011-11-30 |
| END MARKETING DATE: | 0000-00-00 |
CANTHARIS HUMAN OTC DRUG Details:
| Item Description | CANTHARIS from HOMEOLAB USA INC |
| LABELER NAME: | HOMEOLAB USA INC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3([hp_X]/1) |
| START MARKETING DATE: | 2011-11-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60512-9151_bf3ee20b-6d71-4ed3-8de2-a0df5a4a8961 |
| PRODUCT NDC: | 60512-9151 |
| APPLICATION NUMBER: | |
Other LYTTA VESICATORIA Pharmaceutical Manufacturers / Labelers:
